Mercalis
Mark Droke has a diverse work experience spanning multiple companies and roles. Mark currently holds the position of Chief Revenue Officer at TrialCard since October 2021, where they are responsible for revenue generation. Prior to their current role, Mark served as the General Manager of Patient & Provider Services at TrialCard from December 2020 to December 2021.
Before joining TrialCard, Mark worked at Mercalis as the Chief Revenue Officer & GM since November 2015. Mark also held the position of Chief Sales Officer (CSO) at TrialCard from January 2018 to December 2020, where they were responsible for driving sales growth.
Additionally, Mark has worked in senior leadership positions at Valeant Pharmaceuticals and Salix Pharmaceuticals. At Valeant Pharmaceuticals, they served as the General Manager of the Pain Specialty Division from April 2015 to December 2015, where they oversaw all aspects of commercialization and sales force management.
At Salix Pharmaceuticals, Mark held various roles including Senior Area Sales Director, Executive Director of Training, Product Manager, and Regional Sales Manager. In these roles, they led teams, launched new sales forces, and implemented training programs.
Prior to joining Salix Pharmaceuticals, Mark worked at Janssen-Ortho as a District Sales Manager and at Johnson & Johnson as a Regional Training Manager.
Overall, Mark Droke brings extensive experience in revenue generation, sales leadership, and training to their current role as Chief Revenue Officer at TrialCard.
Mark Droke attended the Wharton School from 2013 to 2015, focusing on Executive Leadership. Prior to that, they obtained a Bachelor of Science degree in Political Science and Government from East Tennessee State University, where they studied from 1991 to 1996.
Mercalis
1 followers
Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. The company partners closely with its clients to deliver an end-to-end spectrum of commercial capabilities that work together seamlessly and flexibly. Backed by proven industry expertise and results-driven technology, Mercalis provides the data and strategic insights, patient support services, and healthcare provider engagement tools to help life sciences companies successfully commercialize new products. Above all, Mercalis helps navigate the complex life sciences marketplace to accelerate value and enhance patient lives. Founded in 2000, Mercalis provides commercialization solutions to more than 500 life sciences customers and has provided access and affordability support to millions of patients. The company is headquartered in Morrisville, North Carolina. For more information about Mercalis, please visit www.mercalis.com.